Diabetic Macular Edema (DME) Completed Phase 4 Trials for Pegaptanib (DB04895)

Also known as: Diabetic Macular Edema(DME) / Diabetic Macular Oedema / Macular Edema, Diabetic / Diabetic Macular Edema / Macular edema due to diabetes mellitus (disorder) / Diabetic retinal oedema / Diabetic retinal edema

IndicationStatusPhase
DBCOND0060562 (Diabetic Macular Edema (DME))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01175070Intravitreal Macugen for Ischaemic Diabetic Macular OedemaTreatment
NCT01573572Extension Study to Gather Data on Effect of Macugen on the Corneal EndotheliumOther
NCT01486238Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) StudyTreatment